| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c644138f2071b48b5991a1425d8dde0a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5578
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate |
1998-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd17945cbcf1ff3b22ee288d77b3ec56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80180e66c579068589d584b905f617b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b5c8410e5473486b0720eee581ddfbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f8ed0508de78bb9c1b9753e1e3bb016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7d1d84056fa06de9029f594606fb33e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_577e97c47aff1fb626d015a681dd3d53 |
| publicationDate |
2000-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0975347-A1 |
| titleOfInvention |
Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| abstract |
A diseased state based on acute or chronic obstruction of vessels and/or bronchi, acute or chronic inflammation and/or edema formation is advantageously treated by the combined administration of a PDE inhibitor with either an adenylate cyclase agonist or a guanylate cyclase agonist to a subject in need of such therapy. Administration can be either concurrent or in either order. |
| priorityDate |
1997-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |